
We are developing microfluidic concepts and lab-on-a-chip systems for life sciences applications to (a) advance precision medicine,(b) facilitate quality control of biopharmaceutical products, and (c) reduce animal testing. Our research strategy brings together relevant engineering, analytical and biomedical expertise with the aim of bridging the “research-to-product gaps” in microfluidics, lab-on-a-chip systems, and organ-on-a-chip technology. The main focus of our research is the design, fabrication, and testing of advanced organ-on-a-chip technologies, next-generation microfluidic devices…
Annual Revenue$10M to $25M
Estimated OwnershipBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.